Matthew C Murphy1, Prashanthi Vemuri1, Matthew L Senjem1, Clifford R Jack, Jr.1, Richard L Ehman1, and John Huston, III1
1Mayo Clinic, Rochester, MN, United States
Synopsis
Vascular health is a predictor of cognitive outcomes, but the relationship
between the two remains incompletely understood. Here we tested the hypothesis
that brain stiffness is significantly associated with vascular health as assessed
by white matter hyperintensity (WMH) load and the presence of systemic risk
factors. Through voxel-wise mapping, WMH was associated with decreased
stiffness in periventricular regions, while systemic risk factors were
associated with widespread, lower-amplitude stiffness decreases. Examining the
partial correlations between stiffness, WMH and vascular risk factors,
stiffness was significantly associated with both measures, while WMH and vascular
risk were not significantly correlated after controlling for stiffness.
Introduction
Vascular health is a significant predictor of poor neurological outcomes
including stroke, hemorrhage, dementia and even death.1 Moreover, vascular health impacts cognition
both directly and indirectly via Alzheimer’s disease (AD) pathology.2, 3 Nonetheless, the
relationship between current measures of vascular health and clinical outcomes
remains probabilistic, reflecting an incomplete understanding of the mechanisms
that link the two, and suggesting that additional biomarkers may be beneficial
in bridging the gap. Based on preliminary observations, the hypothesis of this
study is that MR elastography-based biomarkers can provide a global indication
of brain vascular health. To this end,
we evaluated the association between brain stiffness as assessed by MR
elastography with both cerebrovascular disease and systemic vascular health.Materials and methods
This IRB
approved study included 75 participants who had undergone MRE exams and
vascular health assessment after providing written informed consent. MRE data
were acquired as part of previous studies of normal aging and AD.4, 5 Briefly, MRE data were acquired with a modified spin-echo
EPI pulse sequence, 60 Hz vibration, and 3-mm isotropic sampling. Full data
acquisition details can be found in the original manuscripts. Stiffness maps
were estimated using a neural network inversion,6, 7 trained using data generated by a finite difference model
of harmonic motion in a linear viscoelastic, inhomogeneous, and isotropic
material. Cerebrovascular disease was assessed by T2 FLAIR imaging. T2 white
matter hyperintensities (WMH) were segmented with a semi-automated in-house
algorithm,8 and summarized as the log-transformed
volume as a percentage of total intracranial volume. Systemic vascular health
was assessed from the clinical record of each participant as a Cardiovascular
and Metabolic Condition (CMC) score. This score was computed in each
participant as the summation of the presence of hypertension, hyperlipidemia,
cardiac arrhythmias, coronary artery disease, congestive heart failure,
diabetes mellitus, and stroke.3
Two statistical
analyses were performed. First, voxel-wise modeling was performed to
interrogate the topography of stiffness changes associated with each measure of
vascular health. To this end, following spatial normalization of each
participant’s stiffness map to template space,9 a linear model was fit to the data at
each voxel with predictors including age, sex, WMH and CMC. Partial correlation
analysis was also performed to assess the relationship between global brain
stiffness (µ), WMH and CMC. P<0.05 was considered significant.Results
Figure 1 shows the mean stiffness map, as well as the estimated WMH and
CMC effect maps. WMH was associated with decreased stiffness predominantly in
periventricular regions, where hyperintensities are commonly located. On the
other hand, the CMC effect was more widespread with increasing number of
vascular conditions associated with decreased stiffness. The results of the
partial correlation analysis are presented in Figure 2. Without any
corrections, all pairwise correlations between variables of interest (µ, WMH,
CMC) are statistically significant. When age and sex are fixed, the
relationship between WMH and CMC is no longer significant. When a full partial
correlation analysis is performed, µ is still significantly associated with WMH
and CMC, but WMH and CMC are not significantly correlated. Taken together, the
correlation analysis suggests that stiffness is sufficient to explain the
relationship between WMH and CMC, but not vice versa.Conclusion
In summary, brain stiffness demonstrates non-overlapping sensitivity to
both cerebrovascular disease and systemic vascular health. The mechanism for
this decrease in stiffness with diminished vascular health will require further
investigation, but it may reflect decreased perfusion, which is otherwise
difficult to measure in white matter due to the low signal-to-noise ratio of arterial
spin labeling in these regions.10, 11 The results provide
strong motivation for further work to determine the extent to which MRE-based biomarkers
for vascular health can improve the prediction of cognitive outcomes.Acknowledgements
This work was supported by the NIH grants EB001981 and EB027064.References
1. Debette
S, Schilling S, Duperron M-G, Larsson SC, Markus HS. Clinical significance of
magnetic resonance imaging markers of vascular brain injury: a systematic
review and meta-analysis. JAMA neurology 2019;76:81-94.
2. Vemuri P, Lesnick TG, Knopman DS, et
al. Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging.
Ann Neurol 2019;86:866-877.
3. Vemuri P, Lesnick TG, Przybelski SA,
et al. Age, vascular health, and Alzheimer disease biomarkers in an elderly
sample. Ann Neurol 2017;82:706-718.
4. Arani A, Murphy MC, Glaser KJ, et al.
Measuring the effects of aging and sex on regional brain stiffness with MR
elastography in healthy older adults. Neuroimage 2015;111:59-64.
5. Murphy MC, Jones DT, Jack CR, Jr., et
al. Regional brain stiffness changes across the Alzheimer's disease spectrum.
Neuroimage Clin 2016;10:283-290.
6. Murphy MC, Manduca A, Trzasko JD,
Glaser KJ, Huston J, 3rd, Ehman RL. Artificial neural networks for stiffness
estimation in magnetic resonance elastography. Magn Reson Med 2018;80:351-360.
7. Scott JM, Arani A, Manduca A, et al.
Artificial neural networks for magnetic resonance elastography stiffness
estimation in inhomogeneous materials. Med Image Anal 2020;63:101710.
8. Graff-Radford J, Arenaza-Urquijo EM,
Knopman DS, et al. White matter hyperintensities: relationship to amyloid and
tau burden. Brain 2019;142:2483-2491.
9. Schwarz CG, Gunter JL, Ward CP, et
al. [P2–415]: THE MAYO CLINIC ADULT LIFESPAN TEMPLATE: BETTER QUANTIFICATION
ACROSS THE LIFESPAN. Alzheimer's & Dementia 2017;13:P792-P792.
10. van Gelderen P, de Zwart JA, Duyn JH.
Pittfalls of MRI measurement of white matter perfusion based on arterial spin
labeling. Magnetic Resonance in Medicine 2008;59:788-795.
11. van
Osch MJP, Teeuwisse WM, van Walderveen MAA, Hendrikse J, Kies DA, van Buchem
MA. Can arterial spin labeling detect white matter perfusion signal? Magnetic
Resonance in Medicine 2009;62:165-173.